Healthcare AILilly Tops $20B in 2026 Acquisitions, Betting AI Will Compress Drug Development TimelinesSalvado•May 31, 2026
Healthcare AIAI-Designed Antibody BD200 Outperforms Marketed Cancer Drugs in Resistant TumorsSalvado•Apr 19, 2026
Healthcare AIAI-Designed Antibody BD200 Reaches Clinical Trials, Shows Superior Efficacy in Drug-Resistant CancersSalvado•Apr 18, 2026
Healthcare AINVIDIA Expands BioNeMo Platform to Pharmaceutical Giants for AI Drug DiscoverySalvado•Apr 13, 2026
Healthcare AINVIDIA BioNeMo Platform Powers AI Drug Discovery Push Across Major Pharma and BiotechSalvado•Apr 11, 2026
Healthcare AINVIDIA BioNeMo Wins Lilly and Thermo Fisher Partnerships as AI Lab Automation Platforms MultiplySalvado•Apr 9, 2026
Healthcare AIAI-Discovered Therapeutics Advance Through Clinical Trials as Drug Development Timelines CompressSalvado•Mar 24, 2026
